nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PTGS1—Etoposide—sarcoma	0.114	0.314	CbGbCtD
Rosiglitazone—CYP1A2—Dacarbazine—sarcoma	0.104	0.286	CbGbCtD
Rosiglitazone—CYP2C8—Etoposide—sarcoma	0.0655	0.181	CbGbCtD
Rosiglitazone—CYP1A2—Etoposide—sarcoma	0.0507	0.14	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—sarcoma	0.0285	0.0788	CbGbCtD
Rosiglitazone—PPARG—dermis—sarcoma	0.0253	0.0825	CbGeAlD
Rosiglitazone—PPARG—periosteum—sarcoma	0.021	0.0683	CbGeAlD
Rosiglitazone—PPARG—leg—sarcoma	0.0167	0.0545	CbGeAlD
Rosiglitazone—PPARG—forelimb—sarcoma	0.0166	0.0541	CbGeAlD
Rosiglitazone—PPARG—hindlimb—sarcoma	0.0149	0.0486	CbGeAlD
Rosiglitazone—PPARG—appendage—sarcoma	0.0128	0.0417	CbGeAlD
Rosiglitazone—PPARG—Teniposide—Etoposide—sarcoma	0.0122	1	CbGdCrCtD
Rosiglitazone—Ischaemia—Mitoxantrone—sarcoma	0.0103	0.0322	CcSEcCtD
Rosiglitazone—ACSL4—myometrium—sarcoma	0.00982	0.032	CbGeAlD
Rosiglitazone—ACSL4—seminal vesicle—sarcoma	0.00887	0.0289	CbGeAlD
Rosiglitazone—ACSL4—hematopoietic system—sarcoma	0.00843	0.0275	CbGeAlD
Rosiglitazone—ACSL4—connective tissue—sarcoma	0.00812	0.0265	CbGeAlD
Rosiglitazone—PPARG—endothelium—sarcoma	0.00773	0.0252	CbGeAlD
Rosiglitazone—SLCO1B1—mammary gland—sarcoma	0.00722	0.0235	CbGeAlD
Rosiglitazone—ACSL4—cardiac atrium—sarcoma	0.0064	0.0209	CbGeAlD
Rosiglitazone—ACSL4—uterus—sarcoma	0.00637	0.0208	CbGeAlD
Rosiglitazone—PPARG—mammary gland—sarcoma	0.00623	0.0203	CbGeAlD
Rosiglitazone—ALB—mammary gland—sarcoma	0.00584	0.019	CbGeAlD
Rosiglitazone—ACSL4—tendon—sarcoma	0.00558	0.0182	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—sarcoma	0.00541	0.0176	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Thiotepa—sarcoma	0.00478	0.015	CcSEcCtD
Rosiglitazone—CYP2A6—seminal vesicle—sarcoma	0.00469	0.0153	CbGeAlD
Rosiglitazone—Myocardial ischaemia—Mitoxantrone—sarcoma	0.00467	0.0146	CcSEcCtD
Rosiglitazone—ACSL4—testis—sarcoma	0.00462	0.0151	CbGeAlD
Rosiglitazone—SLCO1B1—hematopoietic system—sarcoma	0.0044	0.0143	CbGeAlD
Rosiglitazone—ACSL4—liver—sarcoma	0.00437	0.0142	CbGeAlD
Rosiglitazone—PPARG—embryo—sarcoma	0.00425	0.0139	CbGeAlD
Rosiglitazone—PTGS1—endothelium—sarcoma	0.00413	0.0135	CbGeAlD
Rosiglitazone—Fluid retention—Thiotepa—sarcoma	0.00413	0.0129	CcSEcCtD
Rosiglitazone—CYP2C8—mammary gland—sarcoma	0.00411	0.0134	CbGeAlD
Rosiglitazone—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00397	0.0124	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Thiotepa—sarcoma	0.00387	0.0121	CcSEcCtD
Rosiglitazone—PPARG—hematopoietic system—sarcoma	0.00379	0.0124	CbGeAlD
Rosiglitazone—PPARG—connective tissue—sarcoma	0.00365	0.0119	CbGeAlD
Rosiglitazone—CYP2C9—mammary gland—sarcoma	0.00365	0.0119	CbGeAlD
Rosiglitazone—Hepatic failure—Thiotepa—sarcoma	0.00351	0.011	CcSEcCtD
Rosiglitazone—Hepatic failure—Dactinomycin—sarcoma	0.00348	0.0109	CcSEcCtD
Rosiglitazone—ACSL4—lymph node—sarcoma	0.00335	0.0109	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—sarcoma	0.00334	0.0109	CbGeAlD
Rosiglitazone—PPARG—skin of body—sarcoma	0.0033	0.0108	CbGeAlD
Rosiglitazone—Cardiac failure—Thiotepa—sarcoma	0.00323	0.0101	CcSEcCtD
Rosiglitazone—Hepatic failure—Vincristine—sarcoma	0.00311	0.00975	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Mitoxantrone—sarcoma	0.003	0.00941	CcSEcCtD
Rosiglitazone—PPARG—uterus—sarcoma	0.00287	0.00934	CbGeAlD
Rosiglitazone—CYP2C19—hematopoietic system—sarcoma	0.00287	0.00934	CbGeAlD
Rosiglitazone—Cardiac failure—Mitoxantrone—sarcoma	0.00279	0.00874	CcSEcCtD
Rosiglitazone—PPARG—lymphoid tissue—sarcoma	0.00267	0.00871	CbGeAlD
Rosiglitazone—PPARG—tendon—sarcoma	0.00251	0.00819	CbGeAlD
Rosiglitazone—CYP2C8—hematopoietic system—sarcoma	0.0025	0.00816	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Etoposide—sarcoma	0.0025	0.00783	CcSEcCtD
Rosiglitazone—Weight increased—Thiotepa—sarcoma	0.00248	0.00777	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Thiotepa—sarcoma	0.00246	0.0077	CcSEcCtD
Rosiglitazone—PPARG—bone marrow—sarcoma	0.00243	0.00793	CbGeAlD
Rosiglitazone—Hyperlipidaemia—Epirubicin—sarcoma	0.00243	0.0076	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00239	0.00749	CcSEcCtD
Rosiglitazone—CYP1A2—hematopoietic system—sarcoma	0.00234	0.00763	CbGeAlD
Rosiglitazone—Cardiac failure—Etoposide—sarcoma	0.00232	0.00727	CcSEcCtD
Rosiglitazone—CYP2A6—liver—sarcoma	0.00231	0.00753	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Thiotepa—sarcoma	0.0023	0.0072	CcSEcCtD
Rosiglitazone—Pleural effusion—Epirubicin—sarcoma	0.00229	0.00716	CcSEcCtD
Rosiglitazone—SLCO1B1—liver—sarcoma	0.00228	0.00743	CbGeAlD
Rosiglitazone—Hyperlipidaemia—Doxorubicin—sarcoma	0.00225	0.00703	CcSEcCtD
Rosiglitazone—CYP2C9—hematopoietic system—sarcoma	0.00222	0.00724	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00219	0.00685	CcSEcCtD
Rosiglitazone—Hepatitis—Dactinomycin—sarcoma	0.00217	0.00678	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Thiotepa—sarcoma	0.00214	0.00672	CcSEcCtD
Rosiglitazone—Weight increased—Mitoxantrone—sarcoma	0.00214	0.00671	CcSEcCtD
Rosiglitazone—PTGS1—seminal vesicle—sarcoma	0.00213	0.00696	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Vincristine—sarcoma	0.00213	0.00666	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Mitoxantrone—sarcoma	0.00212	0.00665	CcSEcCtD
Rosiglitazone—Pleural effusion—Doxorubicin—sarcoma	0.00211	0.00662	CcSEcCtD
Rosiglitazone—Myocardial infarction—Vincristine—sarcoma	0.00211	0.00662	CcSEcCtD
Rosiglitazone—PPARG—testis—sarcoma	0.00208	0.00678	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00207	0.00648	CcSEcCtD
Rosiglitazone—Myocardial infarction—Mitoxantrone—sarcoma	0.00206	0.00644	CcSEcCtD
Rosiglitazone—Erythema multiforme—Dactinomycin—sarcoma	0.00205	0.00641	CcSEcCtD
Rosiglitazone—Eye disorder—Thiotepa—sarcoma	0.00204	0.00639	CcSEcCtD
Rosiglitazone—PTGS1—hematopoietic system—sarcoma	0.00203	0.00661	CbGeAlD
Rosiglitazone—Cardiac disorder—Thiotepa—sarcoma	0.00203	0.00634	CcSEcCtD
Rosiglitazone—Immune system disorder—Thiotepa—sarcoma	0.00197	0.00617	CcSEcCtD
Rosiglitazone—Sinusitis—Mitoxantrone—sarcoma	0.00197	0.00617	CcSEcCtD
Rosiglitazone—PPARG—liver—sarcoma	0.00197	0.00641	CbGeAlD
Rosiglitazone—PTGS1—connective tissue—sarcoma	0.00195	0.00637	CbGeAlD
Rosiglitazone—ALB—testis—sarcoma	0.00195	0.00636	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Epirubicin—sarcoma	0.00192	0.00603	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Vincristine—sarcoma	0.0019	0.00596	CcSEcCtD
Rosiglitazone—Malnutrition—Thiotepa—sarcoma	0.0019	0.00595	CcSEcCtD
Rosiglitazone—Hepatitis—Mitoxantrone—sarcoma	0.00188	0.0059	CcSEcCtD
Rosiglitazone—ALB—liver—sarcoma	0.00184	0.00601	CbGeAlD
Rosiglitazone—Back pain—Thiotepa—sarcoma	0.00184	0.00576	CcSEcCtD
Rosiglitazone—Cardiac disorder—Vincristine—sarcoma	0.0018	0.00562	CcSEcCtD
Rosiglitazone—PTGS1—smooth muscle tissue—sarcoma	0.00179	0.00583	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.00178	0.00558	CcSEcCtD
Rosiglitazone—PTGS1—skin of body—sarcoma	0.00176	0.00575	CbGeAlD
Rosiglitazone—Anaemia—Thiotepa—sarcoma	0.00176	0.0055	CcSEcCtD
Rosiglitazone—Anaemia—Dactinomycin—sarcoma	0.00174	0.00546	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00173	0.00542	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Etoposide—sarcoma	0.00172	0.00539	CcSEcCtD
Rosiglitazone—Myocardial infarction—Etoposide—sarcoma	0.00171	0.00536	CcSEcCtD
Rosiglitazone—Leukopenia—Thiotepa—sarcoma	0.0017	0.00533	CcSEcCtD
Rosiglitazone—Leukopenia—Dactinomycin—sarcoma	0.00169	0.00529	CcSEcCtD
Rosiglitazone—CYP2D6—hematopoietic system—sarcoma	0.00167	0.00544	CbGeAlD
Rosiglitazone—Fluid retention—Epirubicin—sarcoma	0.00166	0.0052	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Etoposide—sarcoma	0.00165	0.00517	CcSEcCtD
Rosiglitazone—Hypertension—Thiotepa—sarcoma	0.00164	0.00514	CcSEcCtD
Rosiglitazone—Back pain—Vincristine—sarcoma	0.00163	0.0051	CcSEcCtD
Rosiglitazone—Myalgia—Thiotepa—sarcoma	0.00162	0.00507	CcSEcCtD
Rosiglitazone—Arthralgia—Thiotepa—sarcoma	0.00162	0.00507	CcSEcCtD
Rosiglitazone—Myalgia—Dactinomycin—sarcoma	0.00161	0.00503	CcSEcCtD
Rosiglitazone—Back pain—Mitoxantrone—sarcoma	0.00159	0.00497	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—sarcoma	0.00156	0.00488	CcSEcCtD
Rosiglitazone—Anaemia—Vincristine—sarcoma	0.00156	0.00488	CcSEcCtD
Rosiglitazone—PTGS1—cardiac atrium—sarcoma	0.00154	0.00502	CbGeAlD
Rosiglitazone—Infection—Thiotepa—sarcoma	0.00154	0.00482	CcSEcCtD
Rosiglitazone—Oedema—Dactinomycin—sarcoma	0.00154	0.00482	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—sarcoma	0.00154	0.00481	CcSEcCtD
Rosiglitazone—PTGS1—uterus—sarcoma	0.00153	0.005	CbGeAlD
Rosiglitazone—Infection—Dactinomycin—sarcoma	0.00153	0.00479	CcSEcCtD
Rosiglitazone—Nervous system disorder—Thiotepa—sarcoma	0.00152	0.00476	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Thiotepa—sarcoma	0.00152	0.00475	CcSEcCtD
Rosiglitazone—Anaemia—Mitoxantrone—sarcoma	0.00152	0.00475	CcSEcCtD
Rosiglitazone—Leukopenia—Vincristine—sarcoma	0.00151	0.00472	CcSEcCtD
Rosiglitazone—PPARG—lymph node—sarcoma	0.00151	0.00491	CbGeAlD
Rosiglitazone—Thrombocytopenia—Dactinomycin—sarcoma	0.00151	0.00472	CcSEcCtD
Rosiglitazone—CYP2C19—liver—sarcoma	0.00148	0.00484	CbGeAlD
Rosiglitazone—Erythema multiforme—Etoposide—sarcoma	0.00148	0.00464	CcSEcCtD
Rosiglitazone—Leukopenia—Mitoxantrone—sarcoma	0.00147	0.0046	CcSEcCtD
Rosiglitazone—Eye disorder—Etoposide—sarcoma	0.00146	0.00459	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—sarcoma	0.00146	0.00457	CcSEcCtD
Rosiglitazone—Cardiac disorder—Etoposide—sarcoma	0.00145	0.00456	CcSEcCtD
Rosiglitazone—Hypertension—Vincristine—sarcoma	0.00145	0.00455	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—sarcoma	0.00145	0.00455	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—sarcoma	0.00144	0.00451	CcSEcCtD
Rosiglitazone—Myalgia—Vincristine—sarcoma	0.00143	0.00449	CcSEcCtD
Rosiglitazone—Hypertension—Mitoxantrone—sarcoma	0.00142	0.00444	CcSEcCtD
Rosiglitazone—Immune system disorder—Etoposide—sarcoma	0.00142	0.00443	CcSEcCtD
Rosiglitazone—ALB—lymph node—sarcoma	0.00141	0.00461	CbGeAlD
Rosiglitazone—Hepatic failure—Epirubicin—sarcoma	0.00141	0.00443	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00141	0.00442	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0014	0.00439	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—sarcoma	0.0014	0.00439	CcSEcCtD
Rosiglitazone—Arthralgia—Mitoxantrone—sarcoma	0.0014	0.00437	CcSEcCtD
Rosiglitazone—Myalgia—Mitoxantrone—sarcoma	0.0014	0.00437	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Vincristine—sarcoma	0.00137	0.00431	CcSEcCtD
Rosiglitazone—Oedema—Vincristine—sarcoma	0.00137	0.00431	CcSEcCtD
Rosiglitazone—CYP2C8—testis—sarcoma	0.00137	0.00447	CbGeAlD
Rosiglitazone—Infection—Vincristine—sarcoma	0.00137	0.00428	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—sarcoma	0.00135	0.00423	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—sarcoma	0.00135	0.00423	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vincristine—sarcoma	0.00135	0.00422	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Vincristine—sarcoma	0.00135	0.00422	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—sarcoma	0.00134	0.00421	CcSEcCtD
Rosiglitazone—PTGS1—tendon—sarcoma	0.00134	0.00438	CbGeAlD
Rosiglitazone—Oedema—Mitoxantrone—sarcoma	0.00134	0.00419	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00134	0.00419	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00134	0.00419	CcSEcCtD
Rosiglitazone—Fatigue—Thiotepa—sarcoma	0.00134	0.00419	CcSEcCtD
Rosiglitazone—Infection—Mitoxantrone—sarcoma	0.00133	0.00417	CcSEcCtD
Rosiglitazone—Fatigue—Dactinomycin—sarcoma	0.00133	0.00415	CcSEcCtD
Rosiglitazone—Constipation—Thiotepa—sarcoma	0.00133	0.00415	CcSEcCtD
Rosiglitazone—Back pain—Etoposide—sarcoma	0.00132	0.00413	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mitoxantrone—sarcoma	0.00131	0.00411	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—sarcoma	0.00131	0.0041	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—sarcoma	0.0013	0.00408	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—sarcoma	0.0013	0.00408	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—sarcoma	0.0013	0.00406	CcSEcCtD
Rosiglitazone—CYP2C8—liver—sarcoma	0.0013	0.00423	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—sarcoma	0.0013	0.00406	CcSEcCtD
Rosiglitazone—Anaemia—Etoposide—sarcoma	0.00126	0.00395	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00125	0.00392	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—sarcoma	0.00125	0.00392	CcSEcCtD
Rosiglitazone—Urticaria—Thiotepa—sarcoma	0.00123	0.00386	CcSEcCtD
Rosiglitazone—Leukopenia—Etoposide—sarcoma	0.00122	0.00383	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00122	0.00382	CcSEcCtD
Rosiglitazone—CYP1A2—liver—sarcoma	0.00121	0.00395	CbGeAlD
Rosiglitazone—Hypoglycaemia—Doxorubicin—sarcoma	0.0012	0.00377	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—sarcoma	0.0012	0.00377	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—sarcoma	0.0012	0.00376	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vincristine—sarcoma	0.00119	0.00372	CcSEcCtD
Rosiglitazone—Fatigue—Vincristine—sarcoma	0.00119	0.00371	CcSEcCtD
Rosiglitazone—Hypertension—Etoposide—sarcoma	0.00118	0.00369	CcSEcCtD
Rosiglitazone—Constipation—Vincristine—sarcoma	0.00118	0.00368	CcSEcCtD
Rosiglitazone—Fatigue—Mitoxantrone—sarcoma	0.00115	0.00362	CcSEcCtD
Rosiglitazone—CYP2C9—liver—sarcoma	0.00115	0.00375	CbGeAlD
Rosiglitazone—Constipation—Mitoxantrone—sarcoma	0.00114	0.00359	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—sarcoma	0.00114	0.00356	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Etoposide—sarcoma	0.00111	0.00349	CcSEcCtD
Rosiglitazone—Asthenia—Thiotepa—sarcoma	0.00111	0.00348	CcSEcCtD
Rosiglitazone—PTGS1—testis—sarcoma	0.00111	0.00362	CbGeAlD
Rosiglitazone—Infection—Etoposide—sarcoma	0.00111	0.00347	CcSEcCtD
Rosiglitazone—Asthenia—Dactinomycin—sarcoma	0.0011	0.00346	CcSEcCtD
Rosiglitazone—Pruritus—Thiotepa—sarcoma	0.0011	0.00344	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Etoposide—sarcoma	0.00109	0.00342	CcSEcCtD
Rosiglitazone—Urticaria—Mitoxantrone—sarcoma	0.00106	0.00333	CcSEcCtD
Rosiglitazone—Diarrhoea—Thiotepa—sarcoma	0.00106	0.00332	CcSEcCtD
Rosiglitazone—Diarrhoea—Dactinomycin—sarcoma	0.00105	0.0033	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—sarcoma	0.00105	0.00329	CcSEcCtD
Rosiglitazone—Dizziness—Thiotepa—sarcoma	0.00103	0.00321	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—sarcoma	0.00102	0.0032	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—sarcoma	0.000999	0.00313	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—sarcoma	0.00099	0.0031	CcSEcCtD
Rosiglitazone—Asthenia—Vincristine—sarcoma	0.000986	0.00309	CcSEcCtD
Rosiglitazone—Rash—Thiotepa—sarcoma	0.000978	0.00306	CcSEcCtD
Rosiglitazone—Dermatitis—Thiotepa—sarcoma	0.000977	0.00306	CcSEcCtD
Rosiglitazone—Headache—Thiotepa—sarcoma	0.000971	0.00304	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00097	0.00304	CcSEcCtD
Rosiglitazone—Rash—Dactinomycin—sarcoma	0.00097	0.00304	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Etoposide—sarcoma	0.000962	0.00301	CcSEcCtD
Rosiglitazone—Asthenia—Mitoxantrone—sarcoma	0.000961	0.00301	CcSEcCtD
Rosiglitazone—Fatigue—Etoposide—sarcoma	0.00096	0.00301	CcSEcCtD
Rosiglitazone—Constipation—Etoposide—sarcoma	0.000952	0.00298	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000944	0.00296	CcSEcCtD
Rosiglitazone—Diarrhoea—Vincristine—sarcoma	0.000941	0.00295	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—sarcoma	0.000926	0.0029	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—sarcoma	0.000924	0.0029	CcSEcCtD
Rosiglitazone—Nausea—Thiotepa—sarcoma	0.000921	0.00288	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—sarcoma	0.000918	0.00288	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—sarcoma	0.000916	0.00287	CcSEcCtD
Rosiglitazone—Diarrhoea—Mitoxantrone—sarcoma	0.000916	0.00287	CcSEcCtD
Rosiglitazone—Nausea—Dactinomycin—sarcoma	0.000914	0.00286	CcSEcCtD
Rosiglitazone—CYP2D6—testis—sarcoma	0.000914	0.00298	CbGeAlD
Rosiglitazone—Dizziness—Vincristine—sarcoma	0.000909	0.00285	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000898	0.00281	CcSEcCtD
Rosiglitazone—Urticaria—Etoposide—sarcoma	0.000885	0.00277	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—sarcoma	0.000879	0.00275	CcSEcCtD
Rosiglitazone—Rash—Vincristine—sarcoma	0.000867	0.00271	CcSEcCtD
Rosiglitazone—Dermatitis—Vincristine—sarcoma	0.000866	0.00271	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—sarcoma	0.000866	0.00271	CcSEcCtD
Rosiglitazone—CYP2D6—liver—sarcoma	0.000864	0.00282	CbGeAlD
Rosiglitazone—Connective tissue disorder—Epirubicin—sarcoma	0.000864	0.0027	CcSEcCtD
Rosiglitazone—Headache—Vincristine—sarcoma	0.000861	0.0027	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—sarcoma	0.000857	0.00268	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—sarcoma	0.00085	0.00266	CcSEcCtD
Rosiglitazone—Rash—Mitoxantrone—sarcoma	0.000844	0.00264	CcSEcCtD
Rosiglitazone—Dermatitis—Mitoxantrone—sarcoma	0.000843	0.00264	CcSEcCtD
Rosiglitazone—Headache—Mitoxantrone—sarcoma	0.000839	0.00263	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—sarcoma	0.000831	0.0026	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—sarcoma	0.000821	0.00257	CcSEcCtD
Rosiglitazone—Nausea—Vincristine—sarcoma	0.000817	0.00256	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—sarcoma	0.000816	0.00255	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—sarcoma	0.000813	0.00255	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—sarcoma	0.000806	0.00263	CbGeAlD
Rosiglitazone—Oedema peripheral—Doxorubicin—sarcoma	0.000801	0.00251	CcSEcCtD
Rosiglitazone—Asthenia—Etoposide—sarcoma	0.000799	0.0025	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—sarcoma	0.000799	0.0025	CcSEcCtD
Rosiglitazone—Nausea—Mitoxantrone—sarcoma	0.000795	0.00249	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—sarcoma	0.000794	0.00249	CcSEcCtD
Rosiglitazone—Pruritus—Etoposide—sarcoma	0.000788	0.00247	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—sarcoma	0.000769	0.00241	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—sarcoma	0.000765	0.0024	CcSEcCtD
Rosiglitazone—Diarrhoea—Etoposide—sarcoma	0.000762	0.00239	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—sarcoma	0.00076	0.00238	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—sarcoma	0.000755	0.00236	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—sarcoma	0.00074	0.00232	CcSEcCtD
Rosiglitazone—Dizziness—Etoposide—sarcoma	0.000736	0.00231	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—sarcoma	0.000734	0.0023	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—sarcoma	0.000708	0.00222	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—sarcoma	0.000707	0.00221	CcSEcCtD
Rosiglitazone—Rash—Etoposide—sarcoma	0.000702	0.0022	CcSEcCtD
Rosiglitazone—Dermatitis—Etoposide—sarcoma	0.000702	0.0022	CcSEcCtD
Rosiglitazone—Headache—Etoposide—sarcoma	0.000698	0.00219	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—sarcoma	0.000685	0.00214	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—sarcoma	0.000685	0.00214	CcSEcCtD
Rosiglitazone—Nausea—Etoposide—sarcoma	0.000662	0.00207	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—sarcoma	0.00066	0.00207	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—sarcoma	0.000654	0.00205	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—sarcoma	0.000651	0.00204	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—sarcoma	0.000651	0.00204	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—sarcoma	0.000634	0.00198	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—sarcoma	0.000624	0.00196	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—sarcoma	0.000624	0.00196	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—sarcoma	0.00062	0.00194	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—sarcoma	0.000612	0.00192	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—sarcoma	0.000611	0.00191	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—sarcoma	0.000611	0.00191	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—sarcoma	0.000603	0.00189	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—sarcoma	0.000603	0.00189	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—sarcoma	0.000578	0.00181	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—sarcoma	0.000578	0.00181	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—sarcoma	0.000574	0.0018	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000569	0.00178	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—sarcoma	0.000566	0.00177	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—sarcoma	0.000566	0.00177	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000539	0.00169	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—sarcoma	0.000538	0.00169	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—sarcoma	0.000534	0.00167	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000526	0.00165	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000499	0.00156	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—sarcoma	0.000498	0.00156	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—sarcoma	0.000496	0.00155	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—sarcoma	0.000494	0.00155	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—sarcoma	0.000459	0.00144	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—sarcoma	0.000448	0.0014	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—sarcoma	0.000442	0.00138	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—sarcoma	0.000427	0.00134	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—sarcoma	0.000414	0.0013	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—sarcoma	0.000413	0.00129	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—sarcoma	0.000409	0.00128	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—sarcoma	0.000395	0.00124	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—sarcoma	0.000394	0.00123	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—sarcoma	0.000393	0.00123	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—sarcoma	0.000391	0.00122	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—sarcoma	0.000382	0.0012	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—sarcoma	0.000371	0.00116	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—sarcoma	0.000364	0.00114	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—sarcoma	0.000364	0.00114	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—sarcoma	0.000362	0.00113	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—sarcoma	0.000343	0.00107	CcSEcCtD
